Drugs Controller General of India

Health & Fitness

DCGI approves advanced trials for Biological E. Limited’s COVID- 19 vaccine

New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator…

Read More »
Medical Specialties

Anti-COVID drug ‘Colchicine’ cleared for phase 2 clinical trials 

New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd., Hyderabad, have been given the…

Read More »
Back to top button